EDGAR Filing Documents for 0001104659-12-035929

Form 8-K - Current report:

SEC Accession No. 0001104659-12-035929

Filing Date

2012-05-10

Accepted

2012-05-10 16:11:54

Documents

Period of Report

2012-05-06

Items

Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a12-11841_28k.htm	8-K	61416
2	EX-4.1	a12-11841_2ex4d1.htm	EX-4.1	25337
3	EX-10.1	a12-11841_2ex10d1.htm	EX-10.1	76023
4	EX-10.2	a12-11841_2ex10d2.htm	EX-10.2	52611
5	EX-10.3	a12-11841_2ex10d3.htm	EX-10.3	57259
6	EX-10.4	a12-11841_2ex10d4.htm	EX-10.4	18016
7	EX-10.5	a12-11841_2ex10d5.htm	EX-10.5	74620
8	GRAPHIC	g118412kmi001.jpg	GRAPHIC	2415
	Complete submission text file	0001104659-12-035929.txt		370114

Mailing Address 100 HAYDEN AVENUE LEXINGTON MA 02421

Business Address 100 HAYDEN AVENUE LEXINGTON MA 02421 6174983300

AMAG PHARMACEUTICALS INC. (Filer) CIK: 0000792977 (see all company filings)